ABC | Volume 113, Nº4, October 2019

Short Editorial Pisani & Scanavacca Percutaneous occlusion of left atrial appendage Arq Bras Cardiol. 2019; 113(4):722-724 This is an open-access article distributed under the terms of the Creative Commons Attribution License 10. Reddy VY, Gibson DN, Kar S O’Neill W, Doshi SK, Horton RP, et al. Post- approval U.S. experience with left atrial appendage closure for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2017;69(3):253-61. 11. Boersma LV, Schmidt B, Betts TR Sievert H, Tamburino C, Teiger E, et al. Implant success and safety of left atrial appendage closure with the Watchman device: peri-procedural outcomes from the Ewolution registry. Eur Heart J. 2016;37(31):2465-74. 12. Guerios EE, Chamie F, Montenegro M Saad EB, Brito FS Junior, Caramori PA, et al. First results of the Brazilian Registry of Percutaneous Left Atrial Appendage Closure. Arq Bras Cardiol. 2017;109(5):440-7. 13. Costa MJMD, Ferreira E, Quintella EF Amorim B, Fuchs A, Zajdenverg R, et al. Left atrial appendage closure with amplatzer cardiac plug in nonvalvular atrial fibrillation: safety and long-term outcome. Arq Bras Cardiol. 2017;109(6):541-9. 14. SahinerML, Kaya EB, Coteli CAytemir K. Left atrial appendage transcatheter occlusionwithAmplatzer Amulet device: real life datawithmid-term follow- up results. Arq Bras Cardiol. 2019; 113(4):712-721. 15. HolmesDR,ReddyVY,BuchbinderMetal.TheassessmentoftheWatchman device in patients unsuitable for oral anticoagulation (ASAP-TOO) trial. Am Heart J. 2017 jul;189:68-74. 724